Table 2.
The distribution of risk factors associated with testing format and forthose identified as AHI (NAAT+ HIV antibody–) or HIV+ antibody (B/W reproduction).
| Raw numbers | Percentage | |||
|---|---|---|---|---|
| Risk factor | Male | Female | Male | Female |
| Distribution of risk factors | ||||
| Rapid only | ||||
| Male-to-male | 299 | 0 | 10.3% | 0 |
| Heterosexual sex | 2595 | 3457 | 89.0% | 99.7% |
| Injection drug use | 21 | 9 | 0.7% | 0.3% |
| Total 6381 | 2915 | 3466 | 100.0% | 100% |
| NAAT+rapid | ||||
| Male-to-male | 376 | 0 | 10.1% | 0 |
| Heterosexual sex | 3313 | 3131 | 89.3% | 99.9% |
| Injection drug use | 21 | 4 | 0.6% | 0.1% |
| Total: 6845 | 3710 | 3135 | 100.0% | 100% |
| Acute HIV infection (AHI) | ||||
| Male-to-male | 6 | 0 | 75.0% | 0.0% |
| Heterosexual sex | 2 | 0 | 25.0% | 0.0% |
| Injection drug use | 0 | 0 | 0.0% | 0.0% |
| Total 8 | 8 | 0 | 100.0% | 0.0% |
| HIV+Ab | ||||
| Male-to-male | 31 | 0 | 41.3% | 0.0% |
| Heterosexual sex | 41 | 40 | 54.6% | 100.0% |
| Injection drug use | 3 | 0 | 4.1% | 0.0% |
| Total: 115 | 75 | 40 | 100.0% | 100.0% |